Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$422M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$411M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$351M |
| 4 |
Pfizer
PFE
|
+$331M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.28B |
| 2 |
Meta Platforms (Facebook)
META
|
+$989M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$953M |
| 4 |
Amazon
AMZN
|
+$816M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.06% |
| 2 | Consumer Discretionary | 1.41% |
| 3 | Healthcare | 0.83% |
| 4 | Financials | 0.79% |
| 5 | Industrials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TAIT
11776
DELISTED
Taitron Components
TAIT
| $35.8K | ﹤0.01% |
+10,261
| New | +$35.6K |
|
|
NTBL
11777
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
| $35.8K | ﹤0.01% |
18,735
+14,296
| +322% | +$56.3K |
|
11778
CALL
Blue Ridge Bankshares
BRBS
$353M
| $35.8K | ﹤0.01% |
+11,800
| New | +$36.1K |
|
|
CMCM
11779
CALL
Cheetah Mobile
CMCM
$94M
| $35.6K | ﹤0.01% |
15,600
+3,700
| +31% | +$7.22K |
|
|
PHX
11780
CALL
DELISTED
PHX Minerals
PHX
| $35.4K | ﹤0.01% |
11,000
-2,700
| -20% | -$9.27K |
|
11781
PUT
Cerus
CERS
$546M
| $35.2K | ﹤0.01% |
16,300
-3,400
| -17% | -$5.6K |
|
11782
PUT
Smith Micro Software
SMSI
$16.4M
| $34.9K | ﹤0.01% |
1,053
+23
| +2% | +$854 |
|
11783
PUT
Beyond Air
XAIR
$4.7M
| $34.9K | ﹤0.01% |
45
-27
| -38% | -$21K |
|
11784
Ocean Power Technologies
OPTT
$46.2M
| $34.9K | ﹤0.01% |
+110,370
| New | +$36.5K |
|
|
ITRM
11785
DELISTED
Iterum Therapeutics
ITRM
| $34.5K | ﹤0.01% |
17,533
-30,123
| -63% | -$37.3K |
|
11786
CALL
Aclaris Therapeutics
ACRS
$901M
| $34.4K | ﹤0.01% |
32,800
-384,200
| -92% | -$1.17M |
|
11787
ADC Therapeutics
ADCT
$134M
| $34.3K | ﹤0.01% |
+20,689
| New | +$19.1K |
|
|
LVTX
11788
CALL
DELISTED
LAVA Therapeutics
LVTX
| $34.3K | ﹤0.01% |
21,700
+4,700
| +28% | +$6.71K |
|
|
TVRD
11789
Tvardi Therapeutics
TVRD
$24.1M
| $33.9K | ﹤0.01% |
1,269
-6,706
| -84% | -$278K |
|
11790
AquaBounty Technologies
AQB
$6.54M
| $33.9K | ﹤0.01% |
11,908
+5,788
| +95% | +$16.7K |
|
|
LICY
11791
CALL
DELISTED
Li-Cycle Holdings Corp.
LICY
| $33.8K | ﹤0.01% |
7,288
-11,287
| -61% | -$128K |
|
11792
Cardiff Oncology
CRDF
$76.8M
| $33.7K | ﹤0.01% |
22,781
-57,391
| -72% | -$69.4K |
|
11793
CALL
Black Diamond Therapeutics
BDTX
$129M
| $33.4K | ﹤0.01% |
11,900
-134,600
| -92% | -$316K |
|
|
BMTX
11794
CALL
DELISTED
BM Technologies, Inc.
BMTX
| $33.4K | ﹤0.01% |
+16,300
| New | +$42.2K |
|
|
ZH
11795
Zhihu
ZH
$261M
| $33.2K | ﹤0.01% |
5,907
+1,830
| +45% | +$10.9K |
|
|
CMRX
11796
DELISTED
Chimerix, Inc.
CMRX
| $33.2K | ﹤0.01% |
34,461
-332,913
| -91% | -$322K |
|
11797
Aterian
ATER
$7.69M
| $32.9K | ﹤0.01% |
7,871
+274
| +4% | +$1.06K |
|
11798
Data Storage Corp
DTST
$6.9M
| $32.7K | ﹤0.01% |
+11,363
| New | +$35.6K |
|
|
RBOT
11799
DELISTED
Vicarious Surgical
RBOT
| $32.6K | ﹤0.01% |
+2,965
| New | +$33.1K |
|
11800
MediciNova
MNOV
$73.8M
| $32.6K | ﹤0.01% |
21,745
+8,611
| +66% | +$15.6K |
|
Similar funds
Jeff Yass's Q4 2023 Portfolio in Review
As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.
By sector, the portfolio is most concentrated in Technology at 2.1% of assets, down from 2.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
- Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
- Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
- Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
- Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
- Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
- Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.